Caplin Point Laboratories Ltd Share Price

Overview

Caplin Point Laboratories Ltd share price is currently ₹2,424.79, down by - ₹46.68 (1.89%) from its previous closing price of ₹2,471.47. The share price has declined -6.53% over the past month and gained 13.66% over the past year. The stock's 52-week low and high are ₹1,475.32 and ₹2,674.77, respectively. Caplin Point Laboratories Ltd has a market capitalisation of ₹ 19,470.00 Cr. The share price was last updated on 25 Aug 2026, 03:50 PM IST.

Caplin Point Laboratories Ltd
Caplin Point Laboratories Ltd
CAPLIPOINT
 0.00
- 46.68
1.89%
Healthcare
 0.00(%)1D

Updated: 25 Aug 2026, 03:50:21 pm IST

Market Data

Open Price

 2,449.62

Prev. Close

 2,471.47
 2,412.51

Day Low

 2,470.78

Day High

 1,475.32

52 Week Low

 2,674.77

52 Week High

HealthcarePharmaceuticals & Drugs
CategoryMid Cap

Fundamentals

Quick Bite

Price To Earnings Ratio

27.70

Sector PE

42.03

PB Ratio

6.69

Sector PB

5.83

EPS

87.55

Dividend Yield

0.30

Today's Volume

50.305 K

5 Day Avg. Volume

92.001 K

PEG Ratio

1.61

Market Cap.

₹ 19,470.00 Cr.

StockGro Trade views

Technical Analysis

Forecasts 🧭

Financials

Corporate Actions

ActionsEx-DateRecord-Date
DividendsFinal Dividend of 200% at ₹4/Share
18-Sep-202618-Sep-2026
DividendsInterim Dividend of 200% at ₹4/Share
29-May-202630-May-2026
DividendsFinal Dividend of 150% at ₹3/Share
12-Sep-202512-Sep-2025
DividendsInterim Dividend of 150% at ₹3/Share
30-May-202530-May-2025

Mutual Fund Ownership

Mutual Fund Holder
Jun 26
Shares held
Jul 26
Shares held
UTI Small Cap Fund - Regular Plan - Growth3.74 Lac
3.62 Lac
(3.19%)
UTI Large & Mid Cap Fund - Regular Plan - Growth3.04 Lac
3.00 Lac
(1.4%)
UTI Aggressive Hybrid Fund - Regular Plan - Growth2.67 Lac
2.58 Lac
(3.35%)
UTI Healthcare Fund - Regular Plan - IDCW2.00 Lac
2.15 Lac
(7.5%)
UTI Retirement Fund1.06 Lac
1.02 Lac
(3.08%)

About Caplin Point Laboratories Ltd 👋

Caplin Point Laboratories Limited is an India-based pharmaceutical company with a business model catering predominantly to emerging markets of Latin America and Africa. The Company has also entered regulated markets such as the United States through its Subsidiary, Caplin Steriles Limited. The Company's operations include research & development and manufacturing of finished formulations, active pharmaceutical ingredients (APIs), clinical research, front-end generic presence in Latin America, brand marketing in Francophone Africa and a USFDA/EU-GMP approved injectable facility. In the Regulated Markets, its products include liquid & lyophilized vials, pre-filled syringes, three-pc ophthalmic droppers and pre-mix bags. In the Emerging Markets, its products include tablets, dry syrups - bottles, soft gels, capsules, suppositories, liquid syrups - bottles, liquid injectables in ampoules & vials, lyophilized vials, prefilled syringes (PFS), and emulsion injection in ampoules & vials.

News & Events

Frequently Asked Questions

What is the share price of Caplin Point Laboratories Ltd?

What is the market cap of Caplin Point Laboratories Ltd?

Should I buy Caplin Point Laboratories Ltd stock now?

What is the 52 week high and low of Caplin Point Laboratories Ltd?

Is the Caplin Point Laboratories Ltd stock good to buy?

Is Caplin Point Laboratories Ltd a good buy for the long term?

Is Caplin Point Laboratories Ltd overvalued or undervalued?

What is the PE and PB ratio of Caplin Point Laboratories Ltd?

Start Now